Glucose and Cholesterol Screening for Pediatric Obesity A Training for CHDP Providers Prepared by: The CHDP Nutrition Subcommittee
Goal To ensure that children and adolescents with BMI ≥ 85 th percentile, as well as those who are at risk but not overweight, are screened for the most common medical conditions associated with childhood overweight
Agenda Review the medical conditions associated with pediatric overweight/obesity Summarize the risk factors for complications of pediatric overweight/obesity that need to be identified as part of a health assessment Clarify the guidelines as described in CHDP Provider Information Notices and 05-22
Overweight & Obese Children California children ages 2 to < CDC Pediatric Nutrition Surveillance System growth statistics from CHDP PM160 report
Overweight & Obese Children California children ages 5 to <20 years 2009 CDC Pediatric Nutrition Surveillance System growth statistics from CHDP PM160 report
Accurate Weight & Stature
BMI Percentile Select the appropriate growth chart Record the data Calculate BMI Plot measurements Interpret plotted measurements Boys: 2 to 20 years BMI > 99th % Severely obese > 95th % Obese 85th to < 95 th % Overweight < 5th % Underweight
BMI % Growth Chart Obese Overweight Normal* Underweight Lab Tests (cholesterol & glucose) In-depth Medical Assessment Note in chart: “Counsel & Follow-up” Measurements Weight Height Age Plot Assessment Algorithm + - *Further tests may be warranted depending on family history
Conditions Associated with Childhood Overweight Cardiovascular Conditions High Blood Cholesterol Lipid Disorders Hypertension (HTN) Endocrine Conditions Type 2 Diabetes Insulin Resistance Impaired Glucose Tolerance Menstrual Irregularities Polycystic Ovarian Syndrome Gastrointestinal Conditions Non-Alcoholic Fatty Liver Disease (NAFLD) Gallstones Orthopedic Conditions Accelerated Growth Hip Disorders Psychological Conditions Depression/Self-Esteem Substance Abuse Disordered Eating Discrimination Pulmonary Conditions Asthma Sleep Apnea
Recommended Screening for Children ≥ 5 Years of Age Screen for both cholesterol & glucose* if BMI ≥ 85 th % AND two of the following risk factors (may be repeated as medically necessary): BMI ≥ 95 th % Family history of diabetes Black, Hispanic, American Indian, Asian, Pacific Islander, Native Alaskan One of the following: acanthosis nigricans, HTN, dyslipidemia or polycystic ovarian syndrome Less than 30 minutes activity/day or consistently unbalanced diet *This training is not intended to cover all aspects of type 1 or type 2 diabetes
Recommended Screening for Children ≥ 5 Years of Age Screen for cholesterol if one of the following risk factors is present (may be repeated as medically necessary): One parent or grandparent had heart/vascular disease, heart attack, heart death, heart surgery or stroke at ≤ 55 years of age* One parent has a cholesterol level ≥ 240 mg/dl* * Family history may not be available for all children
Referral & Care Management for Abnormal Test Results Fasting glucose ≥ 126 mg/dl (elevated): counsel & repeat test, endocrinology referral and/or CCS referral* Cholesterol > < 200 mg/dl (borderline): counsel & repeat test in one year* Cholesterol ≥ 200 mg/dl (elevated): cardiac referral and/or CCS referral* *Clinical judgment should be used
Screening Guide
Billing Instructions DescriptionCodeAgeReimbursement Blood glucose – collection & analysis, or collection & handling 255 years through 20 years 11 months $4.34 Blood/serum cholesterol – collection & analysis or collection & handling 265 years through 20 years 11 months $4.03
Completing the PM Blood glucose Use Code 25 and/or 26 ONLY if collecting the sample. Otherwise, denote: “Sent for glucose and/or cholesterol lab.” Laboratories Blood Glucose – Code 25 Cholesterol – Code 26 Blood/Serum Cholesterol
Resources For the AMA 2007 Expert Committee Recommendations, go to: For the AAP policy on lipid screening and heart health in children, go to: American Diabetes Association: Type 2 Diabetes in Children and Adolescents. Pediatrics 105: , 2000
Summary Lab screening is necessary to provide quality care for children who are overweight/obese Glucose and cholesterol screening facilitates early identification of children who are at risk for diabetes and cardiovascular disease Abnormal lab results can help guide providers to initiate early intervention and/or referral to treatment